News | July 24, 2024
Syngene reports drop in Q1 FY25 revenue to Rs. 790 Cr
Reported profit after tax declined 19% year-on-year to Rs 76 crores
Reported profit after tax declined 19% year-on-year to Rs 76 crores
The integrated company delivers a broad portfolio of over 30,000 lab products across microscopy, histology, and other research areas
The Central government’s decision to exempt three more cancer medicines from customs duty is a commendable step towards making cancer drugs more affordable
The innovative ‘Street Safe’ Rapid Testing Kit should be provided to all vendors attending the Food Safety and Certification (FoSTaC) trainings to ensure that safe food is used by the street food vendors across the country
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
This transaction is the third acquisition by three different Japanese players in this segment
Cyclosporine Ophthalmic Nanoemulsion is a preservative-free Nanoemulsion that has been approved in South Korea, Peru and several countries in the Middle East for treatment of dry eye syndrome
Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders
_256_384.jpg)
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
Findings from the SEIMC-GeSIDA Foundation (FSG) PASO-DOBLE study will include treatment efficacy, safety, and weight gain
Subscribe To Our Newsletter & Stay Updated
